| Literature DB >> 29456021 |
Peter Bannerman1, Fuzheng Guo1, Olga Chechneva1, Travis Burns1, Xiaoqing Zhu2, Yan Wang1, Bokyung Kim1, Naveen K Singhal3, Jennifer A McDonough3, David Pleasure4.
Abstract
Canavan disease, a leukodystrophy caused by loss-of-function ASPA mutations, is characterized by brain dysmyelination, vacuolation, and astrogliosis ("spongiform leukodystrophy"). ASPA encodes aspartoacylase, an oligodendroglial enzyme that cleaves the abundant brain amino acid N-acetyl-L-aspartate (NAA) to L-aspartate and acetate. Aspartoacylase deficiency results in a 50% or greater elevation in brain NAA concentration ([NAAB]). Prior studies showed that homozygous constitutive knockout of Nat8l, the gene encoding the neuronal NAA synthesizing enzyme N-acetyltransferase 8-like, prevents aspartoacylase-deficient mice from developing spongiform leukodystrophy. We now report that brain Nat8l knockdown elicited by intracerebroventricular/intracisternal administration of an adeno-associated viral vector carrying a short hairpin Nat8l inhibitory RNA to neonatal aspartoacylase-deficient AspaNur7/Nur7 mice lowers [NAAB] and suppresses development of spongiform leukodystrophy.Entities:
Keywords: Canavan disease; Nat8l knockdown; leukodystrophy
Mesh:
Substances:
Year: 2018 PMID: 29456021 PMCID: PMC5910673 DOI: 10.1016/j.ymthe.2018.01.002
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454